Editas Medicine, Inc.EDITNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank83
3Y CAGR+27.1%
5Y CAGR-14.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+27.1%/yr
vs -11.4%/yr prior
5Y CAGR
-14.9%/yr
Recent acceleration
Acceleration
+38.5pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$40.52M+25.4%
2024$32.31M-58.6%
2023$78.12M+296.3%
2022$19.71M-22.8%
2021$25.54M-71.8%
2020$90.73M+341.9%
2019$20.53M-35.7%
2018$31.94M+132.6%
2017$13.73M+126.8%
2016$6.05M-